Feldman D - Search Results

1

The development of androgen-independent prostate cancer.

Feldman BJ, Feldman D. Feldman BJ, et al. Among authors: feldman d. Nat Rev Cancer. 2001 Oct;1(1):34-45. doi: 10.1038/35094009. Nat Rev Cancer. 2001. PMID: 11900250 Review.

2

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.

Krishnan AV, Feldman D. Krishnan AV, et al. Among authors: feldman d. Endocr Relat Cancer. 2010 Jan 29;17(1):R19-38. doi: 10.1677/ERC-09-0139. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19926709 Review.

3

Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.

Narayanan S, Srinivas S, Feldman D. Narayanan S, et al. Among authors: feldman d. Nat Rev Urol. 2016 Jan;13(1):47-60. doi: 10.1038/nrurol.2015.254. Epub 2015 Dec 8. Nat Rev Urol. 2016. PMID: 26643568 Review.

4

The role of vitamin D in reducing cancer risk and progression.

Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. Feldman D, et al. Among authors: feldman bj. Nat Rev Cancer. 2014 May;14(5):342-57. doi: 10.1038/nrc3691. Epub 2014 Apr 4. Nat Rev Cancer. 2014. PMID: 24705652 Review.

5

Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.

Swami S, Krishnan AV, Wang JY, Jensen K, Horst R, Albertelli MA, Feldman D. Swami S, et al. Among authors: feldman d. Endocrinology. 2012 Jun;153(6):2576-87. doi: 10.1210/en.2011-1600. Epub 2012 Mar 27. Endocrinology. 2012. PMID: 22454149 Free PMC article.

6

Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.

Wang JY, Swami S, Krishnan AV, Feldman D. Wang JY, et al. Among authors: feldman d. Prostate. 2012 Nov;72(15):1628-37. doi: 10.1002/pros.22516. Epub 2012 Mar 27. Prostate. 2012. PMID: 22457201 Free PMC article.

7

Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer.

Srinivas S, Krishnan AV, Colocci N, Feldman D. Srinivas S, et al. Among authors: feldman d. Urology. 2006 May;67(5):1001-6. doi: 10.1016/j.urology.2005.11.004. Urology. 2006. PMID: 16698360 Clinical Trial.

8

Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.

Bhattacharyya RS, Krishnan AV, Swami S, Feldman D. Bhattacharyya RS, et al. Among authors: feldman d. Mol Cancer Ther. 2006 Jun;5(6):1539-49. doi: 10.1158/1535-7163.MCT-06-0065. Mol Cancer Ther. 2006. PMID: 16818513

9

Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.

Swami S, Krishnan AV, Moreno J, Bhattacharyya RS, Gardner C, Brooks JD, Peehl DM, Feldman D. Swami S, et al. Among authors: feldman d. Int J Cancer. 2009 May 1;124(9):2050-9. doi: 10.1002/ijc.24161. Int J Cancer. 2009. PMID: 19127598 Free PMC article. Clinical Trial.

10

Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.

Bhattacharyya RS, Husbeck B, Feldman D, Knox SJ. Bhattacharyya RS, et al. Among authors: feldman d. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):935-40. doi: 10.1016/j.ijrobp.2008.07.005. Epub 2008 Aug 28. Int J Radiat Oncol Biol Phys. 2008. PMID: 18760546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results